Shingles is an infectious disease which is caused by the reactivation of the chickenpox virus or herpes zoster. The common symptoms associated with this infection are development of rashes, ulcers blister and redness on the skin; exhaustion, and itching among others. Vaccines available for the treatment of shingles are Zostavax, Shingrix & SkyZoster, which are manufactured by Merck & Co., Inc., GlaxoSmithKline plc & SK chemicals respectively.
Market Industry Reports (MIR) has published a new report titled “Shingles Vaccine Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2030.” According to the report, the global shingles vaccine market was estimated to be US$ 2,495.0 million by 2025. It is anticipated to grow at a CAGR of ~17.9% from 2020 to 2030.
Get sample copy of Shingles Vaccine Market:
Some of the prominent players in the Shingles Vaccine Market include:
GlaxoSmithKline plc., and Merck & Co., Inc.. and SK Chemicals
Shingles is a Vaccines are biological products which are used to prevent the occurrence of a large number of diseases. Vaccines protect against more than 25 debilitating or life-threatening diseases, including measles, polio, tetanus, diphtheria, meningitis, influenza, tetanus, typhoid and cervical cancer. Vaccines constitutes of a strain of disease-causing microorganism which is present in the form of killed or weakened state. Vaccines can be classified on the basis of strain or serotype i.e. monovalent vaccines and multivalent vaccines. Vaccines may be monovalent or multivalent. A monovalent vaccine contains a single strain of a single antigen (e.g. Measles vaccine), whereas a multivalent vaccine contains two or more strains/serotypes of the same antigen (e.g. OPV).
The growing adoption of shingles vaccine can be attributed to greater level of protection offered by these vaccines as compared to other modes of treatment. Moreover, in the U.S., recommendation of shingles vaccine by federal health officials for individuals above the age of 50, has been crucial in incrementing its demand in the region.
The Shingles Vaccine Market is segmented on the basis of Product, Modality, Cancer Type, End-Users and region.
Shingrix, and Zostavax
Pediatric Patients & Adult Patients
North America, Europe, Asia Pacific, and the Rest of the World (RoW)
As a standard protocol at MIR, all research assignments go through the following rigorous processes.
- Secondary Research
- Primary Research
- Market Size Estimation & Forecasting
- Data Validation & Triangulation
- Report Generation
Have any query? Inquiry about report:
Table of Contents
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecasted Years – 2020 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
Buy this report @
About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Phone: + 91 8956767535